ibrutinib
Janssen,Abbvie
['leusm', 'cll']
phase 3 cll12 data support watch-and-wait approach in early-stage cll #eha2023 #leusm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.